| abstract |
Embodiments of the present disclosure provide a peptoid, which is a compound of formula I or a stereoisomer, a mixture of stereoisomers, or a pharmaceutically acceptable salt thereof, wherein N-R 4 , N-R in formula I 3 , N‑R 2 , N‑R 1 are respectively The peptide has strong binding ability to EGFR protein, and it can not only be used for targeted treatment of EGFR protein-related diseases, but also for imaging detection or prognosis monitoring of EGFR protein-related diseases. |